AstraZeneca Q4 Core Earnings Beat Estimates…
Administrator_India | February 9, 2023 | 0
AstraZeneca PLC (LON:AZN) posted better-than-expected core income in the fourth quarter, thanks to strong demand for its cancer and rare disease therapies that helped make up for waning sales of […]
Recent Comments